Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Apr 12 04:00PM ET
3.19
Dollar change
-0.19
Percentage change
-5.62
%
IndexRUT P/E- EPS (ttm)-2.41 Insider Own42.82% Shs Outstand23.10M Perf Week-0.62%
Market Cap73.69M Forward P/E- EPS next Y-3.22 Insider Trans0.00% Shs Float13.21M Perf Month10.38%
Income-55.61M PEG- EPS next Q-0.78 Inst Own34.16% Short Float4.74% Perf Quarter50.47%
Sales19.31M P/S3.82 EPS this Y30.20% Inst Trans- Short Ratio3.22 Perf Half Y-9.63%
Book/sh4.27 P/B0.75 EPS next Y3.50% ROA- Short Interest0.63M Perf Year-
Cash/sh4.11 P/C0.78 EPS next 5Y21.20% ROE- 52W Range1.62 - 13.20 Perf YTD25.34%
Dividend Est.- P/FCF- EPS past 5Y- ROI-55.69% 52W High-75.83% Beta-
Dividend TTM- Quick Ratio8.57 Sales past 5Y-50.65% Gross Margin85.50% 52W Low96.31% ATR (14)0.50
Dividend Ex-Date- Current Ratio8.57 EPS Y/Y TTM- Oper. Margin-305.77% RSI (14)50.19 Volatility17.76% 16.65%
Employees80 Debt/Eq0.03 Sales Y/Y TTM- Profit Margin-288.05% Recom1.67 Target Price13.00
Option/ShortNo / Yes LT Debt/Eq0.01 EPS Q/Q-4.19% Payout- Rel Volume0.55 Prev Close3.38
Sales Surprise- EPS Surprise15.44% Sales Q/Q-100.00% EarningsMar 21 AMC Avg Volume194.47K Price3.19
SMA203.54% SMA502.69% SMA200-28.24% Trades Volume106,987 Change-5.62%
Date Action Analyst Rating Change Price Target Change
Aug-16-23Initiated SVB Securities Market Perform
Aug-15-23Initiated Piper Sandler Overweight $20
Aug-15-23Initiated BofA Securities Buy $18
Mar-22-24 07:52AM
Mar-21-24 05:06PM
Feb-21-24 06:00AM
Feb-20-24 05:00PM
Nov-27-23 06:00AM
09:49PM Loading…
Nov-09-23 09:49PM
Nov-03-23 06:00AM
Oct-30-23 06:00AM
Sep-28-23 06:00AM
Sep-01-23 05:57PM
Aug-14-23 08:41PM
Aug-04-23 06:30PM
Jul-27-23 07:01PM
05:36PM
Jul-21-23 02:15AM
Turnstone Biologics Corp. operates as a clinical stage biotechnology company. It engages in the business of developing and commercializing therapeutics. The company is focused on developing new medicines to treat and cure patients with solid tumors. Turnstone Biologics was founded in 2015 and is headquartered in La Jolla, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Jerel DavisDirectorJul 25 '23Buy12.00225,0002,700,0002,726,322Jul 27 04:21 PM
Versant Ventures V, LLC10% OwnerJul 25 '23Buy12.00225,0002,700,0002,726,322Jul 27 04:23 PM
ORBIMED ADVISORS LLCDirectorJul 20 '23Buy12.00416,6664,999,9923,099,265Jul 24 04:38 PM
Gupta RishiDirectorJul 20 '23Buy12.00416,6664,999,9923,099,265Jul 24 04:40 PM